What is Nita Ahuja’s Abbott (ABT) share ownership after this Form 4 transaction?

After the reported transaction, Ahuja’s direct holdings total 2,286 Abbott common shares. This reflects the full amount associated with the restricted stock unit award reported in the filing, as indicated in the post-transaction ownership figure.

Abbott Laboratories (NYSE: ABT) director awarded 2,286 RSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ahuja Nita reported acquisition or exercise transactions in this Form 4 filing.

Abbott Laboratories director Nita Ahuja received an equity award of 2,286 common shares-equivalent as a restricted stock unit grant. The award was granted at a price of $0.00 per share under the Abbott Laboratories 2026 Incentive Stock Program.

The units will be settled in Abbott common shares on a one-to-one basis upon the earlier of the director’s separation from service, death, or a change in control as defined in the program. Following this grant, Ahuja’s reported direct holdings total 2,286 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ahuja Nita

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common shares without par value	2,286	$0.00	--

Holdings After Transaction: Common shares without par value — 2,286 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 2,286 shares Grant price per share: $0.00 per share Shares owned after grant: 2,286 shares +1 more

4 metrics

RSU grant size 2,286 shares Restricted stock unit award to director Nita Ahuja

Grant price per share $0.00 per share Price for restricted stock unit award

Shares owned after grant 2,286 shares Total direct holdings following the transaction

Transaction date 2026-04-24 Date of restricted stock unit grant

Key Terms

Restricted stock unit, 2026 Incentive Stock Program, change in control

3 terms

Restricted stock unit financial

"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

2026 Incentive Stock Program financial

"award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program")"

change in control financial

"death, or the occurrence of a change in control (as defined in the Program)"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Form 4 Insider Transactions: What Each Field Means →

04/28/2026 - 06:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ahuja Nita

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

ILLINOIS

60064

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common shares without par value	04/24/2026		A		2,286⁽¹⁾	A	$0	2,286	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

	/s/ Nita Ahuja by Jessica H. Paik, Attorney-in-Fact	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Abbott Laboratories (ABT) director Nita Ahuja report on this Form 4?

Director Nita Ahuja reported receiving an equity award of 2,286 common-share-equivalent restricted stock units. These were granted at $0.00 per share under Abbott’s 2026 Incentive Stock Program and increase her reported direct holdings to 2,286 common shares after the transaction.

How many Abbott Laboratories (ABT) shares are tied to Nita Ahuja’s new award?

The award covers 2,286 common-share-equivalent restricted stock units. Each unit will convert into one Abbott common share under the program’s terms, so the grant represents 2,286 shares that will be delivered when settlement conditions are met.

When will Nita Ahuja’s Abbott (ABT) restricted stock units be paid out?

The restricted stock unit award will be paid in Abbott common shares on a one-to-one basis at the earlier of Ahuja’s separation from service, her death, or a qualifying change in control, as those terms are defined in the company’s 2026 Incentive Stock Program.

What program governs Nita Ahuja’s equity grant at Abbott Laboratories (ABT)?

The grant was made under the Abbott Laboratories 2026 Incentive Stock Program. This plan authorizes restricted stock unit awards that are ultimately settled in Abbott common shares when specific events occur, such as separation from service or a defined change in control.